Skip to content

Activity and tolerability of L. plantarum P 17630, orally administered 5 x 10 9 CFU/capsule

Activity and tolerability of L. plantarum P 17630, orally administered 5 x 10 9 CFU/capsule (PLANTAGYN) : a multicentre, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12669692
Enrollment
150
Registered
2017-07-17
Start date
2015-09-30
Completion date
Unknown
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal candidosis Infections and Infestations Candidiasis of vulva and vagina

Interventions

The participants were assigned to a treatment sequence using a randomization list which is unknown to the Clinical Investigators and laboratory researchers. Half of the females were treated with PLANT

Sponsors

Proge Farm Srl
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women with clinical history of recurrent yeast vaginitis (> 3 relapses within 1 year) 2. Age > 18 years 3. No foods with added probiotics (e.g. yogurts and derivate) and food supplements with probiotics taken in the previous 30 days 4. Ability to follow personal hygiene care 5. The will to cooperate during the study

Exclusion criteria

Exclusion criteria: 1. Women with clinical symptoms of yeast or bacterial vaginitis (e.g. burning, itching, odor fish, vaginal discharge, leucorrhea) 2. Ongoing antimicrobial drugs treatment for vaginal infections 3. Laboratory confirmed bacterial infections (exclusion in case of t0 Nugent score > 7) 4. Menopause 5. Pregnancy (drop-out in case of pregnancy during the study) 6. Chronic antibiotic treatment 7. Chronic corticosteroid treatment 8. Immunodeficiency 9. Diabetes 10. Vaginal probiotics used in the previous 30 days 11. Participation to any clinical studies which could influence genitourinary tract flora

Design outcomes

Primary

MeasureTime frame
Lactobacillary grade (LBG) assessment of vaginal lactobacilli flora, assessed by microscopic vaginal swab examination at t0 (initial visit - baseline), t45 (after 45 days of treatment), t90 (after 90 days of treatment)

Secondary

MeasureTime frame
1. Genetic identification of the probiotic strain L. plantarum P17630 using PCR and the vaginal swabs collected during visits at t0 (initial visit - baseline), t45 (after 45 days of treatment), t90 (after 90 days of treatment) 2. Relapses of Candida spp; each patient communicated to the clinician if any relapses occurred during the 90-day follow-up

Countries

Romania

Contacts

Public ContactNicu Trincu

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 25, 2026